Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

24
Number of overlapping holdings
17.6%
% of XBI's 136 holdings also in HELX
42.9%
% of HELX's 62 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus HELX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XBI |
Weight in HELX |
Overlap | |
---|---|---|---|---|
NATERA INC | 3.5% | 3.1% | 3.1% | |
VERTEX PHARMACEUTICALS INC | 2.6% | 5.6% | 2.6% | |
INSMED INC | 2.6% | 2.1% | 2.1% | |
SAREPTA THERAPEUTICS INC | 2.7% | 1.8% | 1.8% | |
REGENERON PHARMACEUTICALS | 1.7% | 5.3% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to HELX
GILEAD SCIENCES INC | 3.0% | |
INCYTE CORP | 2.9% | |
ADVENTRX PHARMACEUTICALS INC | 2.8% | |
ABBVIE INC | 2.4% | |
AMGEN INC | 2.2% | |
MADRIGAL PHARMACEUTICALS, INC. | 2.2% | |
BIOMARIN PHARMACEUTICAL INC | 2.1% | |
BIOGEN IDEC INC | 2.1% | |
VIKING THERAPEUTICS, INC. | 1.9% | |
NEUROCRINE BIOSCIENCES INC | 1.8% |
XBI Underweight Relative to HELX
MEDPACE HOLDINGS, INC. | -6.4% | |
DANAHER CORP | -5.2% | |
THERMO FISHER SCIENTIFIC INC | -4.9% | |
ELI LILLY & CO | -4.2% | |
KRYSTAL BIOTECH, INC. | -3.8% | |
REGENERON PHARMACEUTICALS | -3.6% | |
SAMSUNG BIOLOGICS CO., LTD. | -3.3% | |
VERTEX PHARMACEUTICALS INC | -3.0% | |
ASTRAZENECA PLC-SPONS ADR | -2.6% | |
BRUKER CORP | -2.4% |